Why a cancer patient had to wait 3 months to get her medication

Why a cancer patient had to wait 3 months to get her medication

Connie Raborn had already survived metastatic breast cancer and a double mastectomy when she was diagnosed with bone cancer on May 4. The 66-year-old Kentwood, Louisiana resident is a Medicare recipient and has health insurance through the military. So her coverage should have been enough to ensure she had the medication she needed after her […]

American Cancer Society: Many opioid drug bills affecting cancer patients pain options

American Cancer Society: Many opioid drug bills affecting cancer patients pain options

Legislative and other efforts to combat prescription opioid abuse are affecting cancer patients’ treatment options for pain in many states, according to the American Cancer Society Cancer Action Network. In its annual review “How Do You Measure Up?,” which analyzes how states are doing in terms of cancer prevention policies against its benchmarks, ACS CAN […]

FDA Expands Recall Of Common Blood Pressure Drug Over Cancer Concern

FDA Expands Recall Of Common Blood Pressure Drug Over Cancer Concern

(CNN) — The US Food and Drug Administration expanded the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure. The FDA initially announced a valsartan recall in July after lab tests discovered that some drugs could […]

Nanoparticle therapy could deliver double blow to cancer

Nanoparticle therapy could deliver double blow to cancer

Killer T cells surround a cancer cell. Credit: NIH A new cancer therapy using nanoparticles to deliver a combination therapy direct to cancer cells could be on the horizon, thanks to research from the University of East Anglia. The new therapy, which has been shown to make breast cancer and prostate cancer tumours more sensitive […]

Sareum Holdings investors receive update on progress of cancer drug

Sareum Holdings investors receive update on progress of cancer drug

Investors in () received an update on the company’s most advanced drugs candidate via (), the NASDAQ-listed group with which Sareum has a licensing deal. SRA737 is a checkpoint kinase-1 (Chk1) inhibitor, one of a new breed of cancer treatments, and is currently phase I/II trials targeting various strains of the killer disease. […]

NICE okays Pfizer blood cancer drug Besponsa after appeal

NICE okays Pfizer blood cancer drug Besponsa after appeal

NICE has changed its mind and recommended regular NHS funding for Pfizer’s Besponsa blood cancer drug, after the manufacturer submitted a new analysis and cut its price. Besponsa (inotuzumab ozogamicin) is approved for refractory B-cell acute lymphoblastic leukaemia, which NICE rejected a year ago in final draft guidance on cost grounds. The drug is typically […]

Arsenic in combination with an existing drug could combat cancer

Arsenic in combination with an existing drug could combat cancer

BOSTON – Investigators have discovered that arsenic in combination with an existing leukemia drug work together to target a master cancer regulator. The team, led by researchers at the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC), is hopeful that the discovery could lead to new treatment strategies for diverse types of cancer. Their […]

FDA approves Western University cancer drug after 30 years

FDA approves Western University cancer drug after 30 years

It’s been a long haul for professor emeritus Duncan Hunter. Thirty years ago he conducted research on a drug called Azedra to treat specific types of adrenal cancer. That drug has just received approval from the U.S. Food and Drug Administration (FDA). “It’s a relief,” said Hunter. “It’s been so long in coming you can’t […]

Patients did not receive full dose of cancer drugs

Patients did not receive full dose of cancer drugs

WATERLOO REGION — A number of cancer patients receiving treatment through the Waterloo Wellington Regional Cancer Program did not receive their full prescribed medication. A review dating back to 2009 found 86 patients potentially missed out on at least 10 per cent of some medications administered intravenously because of the way the tubing was set […]